Alps Group, Inc. operates as a biotechnology company that integrates research and development, medical services, and wellness solutions. The firm has cultivated a diverse pipeline covering various biotechnology research areas. This includes initiatives focused on MyImmune (NK cells), CAR-T cells, COVID-19 mRNA vaccine, diabetes therapeutics, and advancements in stem cell technologies such as induced Pluripotent Stem Cells (iPSCs) and messenger ribonucleic acid (mRNA) platform technology. The firm provides aesthetic treatments, cosmetic procedures, general healthcare and wellness services. The Company’s aesthetic services and cosmetic surgery services include non-surgical aesthetic services and surgical aesthetic services. The company operates a molecular laboratory and a cGMP cell and gene therapy research and cultivation laboratory.
최신 재무제표(Form-10K)에 따르면, Alps Group Inc의 총 자산은 $0이며, 순손실입니다.
ALPS의 주요 재무 비율은 무엇인가요?
Alps Group Inc의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Alps Group Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Alps Group Inc 주요 수익원은 Replacement Parts, Services and Solutions: Industrial - Industrial이며, 최신 수익 발표에서 수익은 4,998,312,000입니다. 지역별로는 South Africa이 Alps Group Inc의 주요 시장이며, 수익은 6,561,564,000입니다.